The Journal Club: Cannabis, Inflammation & Cardiovascular Diseases

by Laura Smith | Aug 9, 2022 | Communications, Journal Club

Discussion around the effects of a cannabinoid receptor 1 antagonist on THC-induced vascular inflammation

Please join us for a conversation about a study published in 2022 in the Journal Cell entitled: “Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation”, in which Dr. Chandy, and Dr. Sitbon discuss the potential therapeutic applications of genistein, a soybean isoflavone, on inflammation, oxidative stress and vascular dysfunction caused by Δ9-THC administration.

Laura Smith

Laura brings extensive knowledge of the pharmaceutical industry and leads patient-focused care at Csequence. Laura’s professional experience includes over 20 years in various roles within the healthcare industry as well as training in the intentional use of plant medicine, a background in community health education, and is a grief recovery specialist. She has a unique educational background with an MBA from Yale University coupled with a MA in Spiritual Psychology from the University of Santa Monica. Laura co-founded and has been co-leading Cadence Communications & Research, a boutique healthcare firm in the pharmaceutical and biotech industry for over 10 years. Laura previously worked as an Investor Relations officer at Amgen. While there, she also held a variety of finance roles to assist marketing teams to optimize decisions related to clinical investments, lifecycle management, product sales and profitability. Prior to that, she was as Hoffmann-La Roche where she participated in their leadership development program and contributed to Roche Labs supporting product launches, business development deals, pricing and product lifecycle decisions.